Larimar: Q2 Earnings Snapshot

August 11, 2022 GMT

BALA CYNWYD, Pa. (AP) _ Larimar Therapeutics, Inc. (LRMR) on Thursday reported a loss of $8.7 million in its second quarter.

On a per-share basis, the Bala Cynwyd, Pennsylvania-based company said it had a loss of 47 cents.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on LRMR at